Posts In: Gubba Pharma In E News

Ayushmann Khurrana to be the face of Cipla Health’s Maxirich

With the campaign, the brand aims to inspire consumers to adopt Maxirich in their daily dietCipla Health has roped in actor Ayushmann Khurrana as a...

Continue Reading

Tata Consumer Products MD Sunil D’Souza on food & non-food business plans

In a recent interview Sharleen D’Souza, Tata Consumer Products MD and CEO Sunil D’Souza shares his strategic roadmap for food and non-food businesses. Q1: Your...

Continue Reading

Pfizer sets up global drug development centre in India

Pfizer has set up a centre to develop APIs and finished dosage forms of differentiated products for global markets, at the IIT Madras Research Park...

Continue Reading

115 API manufacturing units to come up in Gujarat

Reducing its import dependence, one innovation at a time, Gujarat’s pharmaceutical landscape is soon to change and evolve. With some 115 new plants getting manufacturing...

Continue Reading

Novartis’ Netflix moment? Big Pharma launches new on-demand video hub to boost digital engagement with doctors

Novartis is continuing its digital push under CEO Vas Narasimhan with a new Netflix-style approach to help connect with doctors and better learn what content...

Continue Reading

Covid-19: Govt to expedite process of recognition of Biological E Corbevax

The government plans to expedite the process of recognition ofCOVID-19 vaccine Corbevax by other countries while its manufacturer Biological E pursues WHO’s emergency use listing...

Continue Reading

Pills to wellness, Cipla is seeking a new identity

Drugmaker Cipla wants to be more than just a pharmaceutical company selling a pill and aims to play a bigger role in a patient’s journey...

Continue Reading

Aurobindo Pharma gets USFDA nod for generic cancer drug Bortezomib

“Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma (cancer of plasma cells) and is also used to treat adult...

Continue Reading

Julphar to launch over 100 new medicines as part of growth strategy

DUBAI: Gulf Pharmaceutical Industries Julphar has announced its Strategy 2030, an effort to drive transformation that will contribute to higher shareholder returns.According to the Emirates...

Continue Reading